Center of Excellence for Multiple Myeloma
The Center of Excellence for Multiple Myeloma is known throughout the world as a leader in multiple myeloma patient care and translational research. It is the largest multiple myeloma program in New York City and one of the largest in the country. With a high patient volume, including more than 500 new patients each year, we have developed a uniquely focused program. Multiple myeloma is a complex cancer. It is best treated by physicians who see myeloma patients day in and day out and who have an in-depth understanding of myeloma biology.
Our mission is to provide comprehensive, compassionate care for patients with multiple myeloma and related diseases and advance innovative research and personalized treatments that lead to cure.
We provide novel, precision-medicine therapies that offer the best chance for good outcomes with a high quality of life. Our physicians are internationally recognized in the diagnosis and treatment of multiple myeloma at all stages, including Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma, as well as related diseases such as Amyloidosis, Castleman Disease, POEMS Syndrome, and Waldenstrom Macroglobulinemia.
We offer the highest quality of care targeted to your disease for the best possible outcome. You will benefit from our innovative research in genomics, epigenetics, and immunotherapy, and our ability to quickly translate new findings into effective treatments.